10-123754668-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_198148.3(CPXM2):c.2012G>A(p.Arg671Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000321 in 1,557,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_198148.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPXM2 | NM_198148.3 | c.2012G>A | p.Arg671Gln | missense_variant | Exon 13 of 14 | ENST00000241305.4 | NP_937791.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPXM2 | ENST00000241305.4 | c.2012G>A | p.Arg671Gln | missense_variant | Exon 13 of 14 | 1 | NM_198148.3 | ENSP00000241305.3 | ||
CPXM2 | ENST00000615851.4 | c.500G>A | p.Arg167Gln | missense_variant | Exon 13 of 15 | 5 | ENSP00000483180.1 | |||
CPXM2 | ENST00000368854.7 | n.2059G>A | non_coding_transcript_exon_variant | Exon 15 of 20 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251362Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135838
GnomAD4 exome AF: 0.00000285 AC: 4AN: 1405632Hom.: 0 Cov.: 24 AF XY: 0.00000285 AC XY: 2AN XY: 702868
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2012G>A (p.R671Q) alteration is located in exon 13 (coding exon 13) of the CPXM2 gene. This alteration results from a G to A substitution at nucleotide position 2012, causing the arginine (R) at amino acid position 671 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at